U.S. exports of Streptomycins, Derivatives & Their Salts (SITC 54132) totaled $219K in August 2026.
Importers of Streptomycins, Derivatives & Their Salts paid $2K in duties in August 2026, an average duty rate of 1.38% — duty actually collected as a share of the imports that cleared customs, not the published tariff schedule. Streptomycins, Derivatives & Their Salts imports of $125K in August 2026 ran 69% below the year-to-date monthly average of $404K.
Last updated: August 2026 dataStreptomycin and its derivatives — aminoglycoside antibiotics produced by Streptomyces griseus fermentation — are used in human medicine primarily for tuberculosis treatment and in veterinary and agricultural applications, including as a bactericide for certain crops. The agricultural use dimension means that USDA may have regulatory interest alongside FDA's drug import oversight for human-use grades. Global production capacity for streptomycin is relatively narrow compared to other antibiotic classes, and bulk API supply is concentrated in a limited number of fermentation facilities. Importers of pharmaceutical-grade material must ensure compliance with FDA's drug establishment registration requirements and provide pharmacopeial certificates of analysis.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
4 import shipments a month
Yes. Streptomycin registered for use on crops (e.g., to control fire blight in orchards) is regulated as a pesticide by the EPA under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). Importing streptomycin for agricultural use requires that the product be registered with EPA or qualify for an exemption, which is a separate compliance pathway from FDA's pharmaceutical drug import program. Importers should clearly identify the intended end use to determine which regulatory framework applies.
Streptomycin is produced by microbial fermentation rather than chemical synthesis, so batch-to-batch potency and impurity profiles depend heavily on fermentation conditions, strain quality, and downstream purification. Certificates of analysis should specify potency (in IU/mg or µg/mg), identified impurities, and residual solvent levels. These parameters also inform whether the material meets USP or BP pharmacopeial standards required for pharmaceutical-grade import.
Basic heading 434 of 465 in section 5
Basic heading 54132 · $219K of $26.2B
Trade Directory
List your company and tag the 6-digit products you trade, so the companies trading them can find you. Be the first supplier listed.
Exports · August 2026
destination
China and Netherlands together take 56% of it.
customs district
Census does not publish district detail for this classification system.
origin
Census does not publish state detail for this classification system.
entry
Census does not publish port detail for this classification system.
ImportsExports
Imports
$125KYoY · free account
Exports
$219KYoY · free account
12-mo low · imports
Low · free accountOver the twelve months to August 2026, the U.S. imported $4.9M of Streptomycins, Derivatives & Their Salts and exported $2.1M.
Fewer than 6 of the last 12 months reported trade, or the latest month was under $500K; the trend chart is not shown for thin series.
Through August 2026. Source: U.S. Census Bureau.